News Release

Yuji Kogami appointed as new CEO

2023.06.21

As of June 20, 2023, Yuji Kogami has been appointed as new CEO by the Board. He will overlook all functions including R&...

Read More
IAM is announcing a collaboration with the Institute of Physical and Chemical Research (RIKEN) covering multiple therapeutic areas.
- News
2021.05.20
IAM is announcing a collaboration with the Institute of Physical and Chemical Research (RIKEN) covering multiple therape...

Read More
IAM’s CEO, Hiroyuki Kouji, will be presenting a lecture at the 25th meeting of The Japanese Association for Molecular Target Therapy of Cancer (May 26-28)
- News
2021.05.20
IAM’s CEO, Hiroyuki Kouji, will be presenting a lecture at the 25th meeting of The Japanese Association for Molecular Ta...

Read More
Hiroyuki Kouji appointed as new CEO
- News
2020.05.7
As of May 7, 2020, Hiroyuki Kouji has been appointed as new CEO by the Board. He will overlook all functions including R...

Read More
IAM wins Grand Prize in “16th Oita Business Plan Grand Prix”
- News
2019.02.5
IAM’s business model of “Constructing compound library utilizing novel peptide mimicking technology” has been granted gr...

Read More
“Drug Development Cluster Plan” introduced in Oita Godo Shimbun
- News
2018.12.19
Oita Godo Shimbun introduced “Drug Development Cluster Plan” on December 19th, 2018 currently driven by Oita University ...

Read More
We have released Website.

2018.05.30

...

Read More
IAM delivered an address at Open Innovation Conference II.

2018.03.20

...

Read More
IAM as first venture company to be supported by Kyusyu Venture Promotion Committee
- News
2017.12.27
IAM has been founded as a first venture company to be supported by Kyushu Venture Promotion Committee. With this, Hirohi...

Read More